Steady State Analysis and Calculation of
We present the steady states analyses of the model shown in Table S2 . We restrict our analysis to the case with no admission of colonized or infected patients to the hospital, . By setting the time derivatives in Table S2 to zero and solving the equations, we find a disease-free state
To study the existence/stability of , we need to compute the basic reproductive number ( ) associated with . We reorder the components of so that we can separate the two genotypes (TTG-MRSA and VGT-MRSA) easily. The reordered is respectively. Using (S3)-(S6), we can find
and (S8) where are 4 by 4 matrices and is a 4 by 4 matrix of zeros.
The basic reproductive numbers for the TTG-MRSA strain in the absence of VTG-MRSA strain is
where denotes the spectral radius (dominant eigenvalue) of the matrix A.
Similarly, the basic reproductive number for the VGT-MRSA strain in the absence of TTG-MRSA strain is (S10)
Finally, the basic reproductive number for the whole system is . If , the steady state is stable; otherwise is unstable.
Calculating Efficacy of Vaccine (EV) during the lag period
As mentioned in the text, the lag period for host immunity to build after vaccination against the pathogen in question takes several days (assumed to be n days). Due to this fact there will be high incidence of MRSA infection, depending on the force of infection ( ), before the vaccine fully protects the individuals. To take this fact into account in our model, we explored the efficacy of vaccine (EV) during the lag period.
Assume an individual gets vaccinated at time and the vaccine efficacy after vaccination is determined by a strict increasing function that satisfies and . Without loss of generality, we let in the rest of this analysis. We defined the EV as the probability that the vaccinated individual will not get infected within n days after vaccination. Specifically,
where is the probability that the vaccinated individual get infected on j-th day after vaccination, 5 (S12)
Note that we have used the vaccine efficacy at the beginning of the j-th day (instead of the efficacy at the end of that day) to estimate conservatively.
Substituting (S12) into (S11) gives (S13)
As an example, let , , and , we find that from (S13).
